/HRAL

HRAL Stock - Hear AtLast Holdings, Inc.

Q: What is the analyst price target for HRAL?

Analyst price target information is not currently available for HRAL.

Q: What is HRAL's market cap?

Market capitalization information is not currently available for HRAL.

Healthcare|Medical - Instruments & Supplies|OTC

$0.00-10.00%

$0.00 (-10.00%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

100

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.00

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for HRAL

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2020

FY2021

FY2022

FY2023

FY2024

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta0.23

52W High$0.00

52W Low$0.00

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2024	FY2023	FY2022	FY2021	FY2020
Revenue	N/A	N/A	N/A	$3,304	$1,234
Gross Profit	N/A	N/A	N/A	$789	$1,234
Gross Margin	N/A	N/A	N/A	23.9%	100.0%
Operating Income	$-195,691	$-124,931	$-104,310	$-166,790	$-326,300
Net Income	$145,211	$-234,366	$-215,236	$-765,950	$-326,302
Net Margin	N/A	N/A	N/A	-23182.5%	-26442.6%
EPS	$0.00	$-0.00	$-0.00	$-0.00	$-0.00

Company Overview

HearAtLast Holdings, Inc. operates hearing clinics in North America. The company offers hearing assessments and hearing instruments. Its products comprise digital hearing aid instruments and assistive-listening devices, as well as accessories, such as hearing aid wax guards, chargers, cleaners, sound tubes, etc. As of March 31, 2010, HearAtLast Holdings, Inc. had 23 hearing aid clinics within the Wal-Mart structure. The company was formerly known as 226 Music Group, Inc. and changed its name to HearAtLast Holdings, Inc. in 2007. HearAtLast Holdings, Inc. was founded in 2004 and is headquartered in Georgetown, Canada.

Visit Website

Earnings History & Surprises

HRAL

Beat Rate

Last 0 quarters

Avg Surprise

+0%

EPS vs Estimate

Beats / Misses

0/0

Last 12 quarters

Latest EPS

$-0.00

Q4 2023

EPS Surprise History

Q4 23

No data

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q4 2023	Dec 31, 2023	—	$-0.00	—	—

Frequently Asked Questions about HRAL

What is HRAL's current stock price?

Hear AtLast Holdings, Inc. (HRAL) is currently trading at $0.00 per share. The stock has moved -10.00% today.

What is the analyst price target for HRAL?

No analyst price targets are currently available for this stock.

What sector is Hear AtLast Holdings, Inc. in?

Hear AtLast Holdings, Inc. operates in the Healthcare sector, specifically within the Medical - Instruments & Supplies industry. The company is traded on the OTC exchange.

What is HRAL's market cap?

Hear AtLast Holdings, Inc. has a market capitalization of $0.00 billion, making it a small-cap company.

Does HRAL pay dividends?

No, Hear AtLast Holdings, Inc. does not currently pay a dividend to shareholders.